Cresco Labs (CRLBF) 6-K Unaudited Condensed Interim Consolidated Financial Statements

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of May, 2024

000-56241

(Commission File Number)

Cresco Labs Inc.(Exact name of Registrant as specified in its charter)

600 W. Fulton Street, Suite 800
Chicago, IL 60661
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☐    Form 40-F ☒

Exhibit Index
Exhibit No.	Description
99.1	Unaudited Condensed Interim Consolidated Financial Statements for the three months ended March 31, 2024 and 2023
99.2	Management Discussion and Analysis of Financial Condition and Results of Operations for the three months ended March 31, 2024 and 2023
99.3	News Release dated May 15, 2024

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CRESCO LABS INC.
Date: May 15, 2024	By:	/s/ Charles Bachtell
		Charles Bachtell
		Chief Executive Officer